The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the microb1
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1
The researcher has received a runner’s-up prize in the Dr. Font Prize category, which recognises the best research articles published, with potential1
Mediterranean diet or mindfulness-based stress reduction interventions during pregnancy reduce the prevalence of low birth weight by 29-36% as well a1
On Friday, 26 November, the dissemination seminar "Immunotherapy 2.0 in lymphoma: how to design personalized therapies" for patients and relatives wa1
The Hospital Clínic-IDIBAPS researcher has been awarded in the basic research category.
The biotechnological pharmaceutical company HIPRA has received authorization from the Spanish Agencyfor Medicines and Health Products (AEMPS) to sta1
On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organization1
On 16 and 17 November, as part of 2021 Science Week, IDIBAPS is organizing a new edition of Generació Ciència (Generation Science), outdoor science w1
The researcher at the Hospital Clínic-IDIBAPS has received recognition for her study on mantle cell lymphomas published in the year 2020 in the journ1
